Advertisement
OtherMinireview

Protease-activated receptor 2: a promising therapeutic target for women's cancers

Himani Shah, David P Fairlie and Junxian Lim
Journal of Pharmacology and Experimental Therapeutics May 6, 2024, JPET-MR-2024-002176; DOI: https://doi.org/10.1124/jpet.124.002176

Article Information

JPET-MR-2024-002176
DOI 
https://doi.org/10.1124/jpet.124.002176
PubMed 
38719478
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online May 6, 2024.
Copyright & Usage 
Copyright © 2024 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Himani Shah1,
  2. David P Fairlie2,*, and
  3. Junxian Lim1,*
  1. 1Institute for Molecular Bioscience, University of Queensland, Australia
  2. 2Institute for Molecular Bioscience, The University of Queensland, Australia
  1. ↵* Corresponding Author:
    Junxian Lim, Institute for Molecular Bioscience, University of Queensland, The University of Queensland, Brisbane, 4072, Australia. E-mail: j.lim{at}imb.uq.edu.au
  2. * Corresponding Author; email: j.lim{at}imb.uq.edu.au

Statistics from Altmetric.com

Article usage

Article usage: May 2024 to December 2024

AbstractFullPdf
May 20246050168
Jun 2024397075
Jul 2024445044
Aug 2024420024
Sep 2024344037
Oct 2024337029
Nov 2024421024
Dec 2024259020

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherMinireview

PAR2 in women's cancers

Himani Shah, David P Fairlie and Junxian Lim
Journal of Pharmacology and Experimental Therapeutics May 6, 2024, JPET-MR-2024-002176; DOI: https://doi.org/10.1124/jpet.124.002176
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement